Skip to content

BWINDI

Active
Private limited companyfounded 2023active for 3 yearsRijsenbergstraat 34, 9000 Gent, BelgiumKBO/BCE: BE 0804.870.168
Summary

BWINDI has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €79,868 and a net result of €35,747. Equity is growing by about 81% per year across the filed financial years. Its solvency ranks better than 95% of 20,453 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€81,781total assets 2025
Equity
€79,868
Profit
€35,747
Turnover not published (micro format)
Financial health
98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 183 days early1 of 2 deeds read
Why 98raises riskFounded in 2023lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 40.54, cash €66,796Equity €79,868 (97.7% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 86% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 97.7% of total assets
Liquidity 100+37
short-term debt 2.3% · cash 81.7%
Profitability 100=
return on assets 43.7%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,071 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025highest value 01-2026: 0.1%● unchanged vs 12-2025highest value 02-2026: < 0.1%▼ -0.1 percentage points vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €7,000 on 30-day terms is acceptable
Liquidity ample (current ratio 40.54, compared with 10.67 in 2024, above the usual 1.5; short-term debt: 2.3% and cash: 81.7% of total assets), and 2.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 95% on liquidity, 80% on profitability and 87% on growth.

The bankruptcy probability was computed on 16-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 40.54, cash €66,796
NBB · annual accounts
lowers risk · Equity €79,868 (97.7% of total assets)
NBB · annual accounts
raises risk · Founded in 2023
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-01-2026, 183 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
183 days early
2024
55 days early
2023
44 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 94 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 June (3 of the last 3 filed years within 128 days of that day).
Companies Code · seven months
Where today falls in the filing period
17-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Liquidity more than triplescurrent ratio 40.54
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, micro format

Equity
€79,868▲ 81.0%
2024 · €44,121
Total assets
€81,781▲ 69.9%
2024 · €48,128
Net result
€35,747▼ 1.7%
2024 · €36,373
Working capital
€75,643▲ 95.2%
2024 · €38,752
Trend over the years

2023 to 2025, 3 financial years

The operating result falls in 2025; 2025 is 3% below 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€44,600 2025 Net result€35,747 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202320242025
Operating result€8,787-€45,752▲ 421%€44,600▼ 2.5%
Net result€6,937below the sector's middle half-€36,373within the sector's middle half▲ 424%€35,747within the sector's middle half▼ 1.7%
Equity€8,607below the sector's middle half-€44,121below the sector's middle half▲ 413%€79,868within the sector's middle half▲ 81.0%
Total assets€9,872below the sector's middle half-€48,128below the sector's middle half▲ 388%€81,781below the sector's middle half▲ 69.9%
Debt€1,265-€4,008▲ 217%€1,913▼ 52.3%
Working capital€8,607below the sector's middle half-€38,752within the sector's middle half▲ 350%€75,643within the sector's middle half▲ 95.2%
Solvency87.2%above the sector's middle half-91.7%above the sector's middle half▲ 4.5pp97.7%above the sector's middle half▲ 6.0pp
Current ratio7.80above the sector's middle half-10.67above the sector's middle half▲ 2.8740.54above the sector's middle half▲ 29.88
Return on assets (ROA)70.3%above the sector's middle half-75.6%above the sector's middle half▲ 5.3pp43.7%above the sector's middle half▼ 31.9pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €81,781
Fixed assets €4,225 ▼ 21.3%
Current assets €77,556 ▲ 81.4%
Equity and liabilities €81,781
Equity €79,868 ▲ 81.0%
Debt €1,913 ▼ 52.3%
Debt's share of the balance-sheet total falls from 8.3% to 2.3%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€45,744▼
2024 · €46,105
Cash flow
€36,891▲
2024 · €36,725
Debt to equity
0.02▼
2024 · 0.09
ROE
44.8%▼
2024 · 82.4%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€1,913▼
2024 · €4,008
Income taxes
€9,357▲
2024 · €9,240
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.8% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
95.8% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 35 lines
Balance sheet Code20242025
Assets
Total assets20/58€48,128€81,781▲
Fixed assets21/28€5,369€4,225▼
Tangible fixed assets22/27€5,369€4,225▼
Furniture and vehicles24€5,369€4,225▼
Current assets29/58€42,760€77,556▲
Current investments50/53€30,000€0▼
Cash at bank and in hand54/58€4,823€66,796▲
Deferred charges and accrued income490/1€7,937€10,760▲
Equity and liabilities
Total equity and liabilities10/49€48,128€81,781▲
Equity10/15€44,121€79,868▲
Contributions10/11€2,500€2,500=
Profit (loss) carried forward14€41,621€77,368▲
Amounts payable17/49€4,008€1,913▼
Amounts payable within one year42/48€4,008€1,913▼
Trade debts44€2,006€1,227▼
Suppliers440/4€2,006€1,227▼
Taxes, remuneration and social security45€240€299▲
Taxes450/3€240€299▲
Other amounts payable47/48€1,762€387▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€352€1,144▲
Other operating charges640/8€0€144▲
Gross operating margin9900€46,105€45,888▼
Operating profit (loss)9901€45,752€44,600▼
Financial income75/76B€0€658▲
Recurring financial income75€0€658▲
Financial charges65/66B€140€154▲
Recurring financial charges65€140€154▲
Profit (loss) for the period before taxes9903€45,613€45,104▼
Income taxes67/77€9,240€9,357▲
Profit (loss) for the period9904€36,373€35,747▼
Profit (loss) for the period to be appropriated9905€36,373€35,747▼
Appropriation of the result
Profit (loss) to be appropriated9906€42,480€77,368▲
Profit (loss) brought forward from the previous period14P€6,107€41,621▲
Profit to be distributed694/7€859€0▼
Return on contributions (dividend)694€859€0▼

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€352€1,144▲ 225%
Other operating charges640/8€50€0€144-
Gross operating margin9900€8,837€46,105€45,888▼ 0.5%
Operating profit (loss)9901€8,787€45,752€44,600▼ 2.5%
Financial income75/76B-€0€658▲ 6,583,900%
Recurring financial income75-€0€658▲ 6,583,900%
Financial charges65/66B€25€140€154▲ 10.1%
Recurring financial charges65€25€140€154▲ 10.1%
Profit (loss) for the period before taxes9903€8,762€45,613€45,104▼ 1.1%
Income taxes67/77€1,825€9,240€9,357▲ 1.3%
Profit (loss) for the period9904€6,937€36,373€35,747▼ 1.7%
Profit (loss) for the period to be appropriated9905€6,937€36,373€35,747▼ 1.7%
Line202320242025Change
Assets
Total assets20/58€9,872€48,128€81,781▲ 69.9%
Fixed assets21/28-€5,369€4,225▼ 21.3%
Tangible fixed assets22/27-€5,369€4,225▼ 21.3%
Furniture and vehicles24-€5,369€4,225▼ 21.3%
Current assets29/58€9,872€42,760€77,556▲ 81.4%
Current investments50/53-€30,000€0▼ 100%
Cash at bank and in hand54/58€7,432€4,823€66,796▲ 1,285%
Deferred charges and accrued income490/1€2,440€7,937€10,760▲ 35.6%
Equity and liabilities
Total equity and liabilities10/49€9,872€48,128€81,781▲ 69.9%
Equity10/15€8,607€44,121€79,868▲ 81.0%
Contributions10/11€2,500€2,500€2,500=
Profit (loss) carried forward14€6,107€41,621€77,368▲ 85.9%
Amounts payable17/49€1,265€4,008€1,913▼ 52.3%
Amounts payable within one year42/48€1,265€4,008€1,913▼ 52.3%
Trade debts44€110€2,006€1,227▼ 38.8%
Suppliers440/4€110€2,006€1,227▼ 38.8%
Taxes, remuneration and social security45€325€240€299▲ 24.9%
Taxes450/3€325€240€299▲ 24.9%
Other amounts payable47/48€830€1,762€387▼ 78.1%
Line202320242025Change
Profit (loss) for the period9904€6,937€36,373€35,747▼ 1.7%
+ Depreciation and write-downs630-€352€1,144▲ 225%
Operating cash flow (approximation)€6,937€36,725€36,891▲ 0.5%
Investment in fixed assets (approximation)--€0-
Change in cash--€2,609€61,973-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (3)
Financial year Type Filed Reference
31-12-2025 micro format 29-01-2026 2026-00017569
31-12-2024 micro format 06-06-2025 2025-00122406
31-12-2023 micro format 17-06-2024 2024-00132373

Similar companies · same sector, comparable size

Of the 16,577 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,106. 6,031 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Subsidies and aid

Flemish government

2023 to 2025 · 3 entries · €2,517 awarded · €2,517 paid
Year Entries AwardedPaid
2025 1 €1,692€867
2024 1 €825€825
2023 1 €0€825
Schemes
3 entries · €2,517 · €2,517 paid · Fonds voor Innoveren en Ondernemen

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 1 of 2 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

On 17 August 2023, BWINDI was incorporated as a private limited company.1 The name was changed to BWINDI in 2025.2 Total assets went from €9,872 in 2023 to €81,781 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 19-03-2025
  3. 3National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
29-01
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial Liquidity more than triplescurrent ratio 40.54
Current ratio from 10.67 to 40.54; short-term debt falls from €4,008 to €1,913.
06-06
NBB filing Annual accounts filed
financial year 2024 · micro format
19-03
Gazette deed Appointment: DEJONCKHEERE Astrid (statutory director)
Name change · Amendment of the articles · Capital7 facts ▸
  • General meeting, “eenparigheid van stemmen, buitengewone algemene vergadering” (deed in Dutch)
  • Name change, BWINDI
  • Amendment of the articles
  • Other provision, “statutair onbeschikbaar eigen vermogen” (deed in Dutch)
  • Capital
  • Director appointment, DEJONCKHEERE Astrid (statutory director)
  • Power of attorney (2 times)
2024
31-12
Financial Highest result from 2023 to 2025net €36,373 ▲424%
Operating result €45,752, net result €36,373, both a record.
17-06
NBB filing Annual accounts filed
financial year 2023 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded17-08-2023
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0804870168
Also 9925:BE0804870168
Registered 26-09-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 17 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2023
registered office establishment The establishment unit on the map
Ground area
132 m²
Building footprint
80 m²
Building volume
681 m³
Parcel 44809I0250/00E002, Flanders · tallest building 10.5 m. Linked by address, not a title deed.
1 establishment unit
Dr. Astrid Dejonckheere, kinder- en jeugdpsychiater
Rijsenbergstraat 34, 9000 GentSpecialist medical practice
since 2023unit no. 2.349.966.441
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
44809I0250/00E002 Flanders 132 m² 1 · 80 m² 10.5 m · 3
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
BWINDI
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Vlaams Gewest, bijhuizen,exploitatiezetels,administratieve zetels,filialen en agentschappen in België en in het buitenland oprichten” (deed in Dutch)

deed of 19-03-2025

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
“Artikel 16. VERTEGENWOORDIGINGSBEVOEGDHEID Iedere bestuurder, afzonderlijk optredend, is bevoegd om de vennootschap te vertegenwoordigen in…”
Board ruleHow the board is made up, meets and takes decisions.
“Een of meer bestuurders, natuurlijke of rechtspersonen,al dan niet aandeelhouder” (deed in Dutch)

deed of 19-03-2025

Capital, shares and profit

Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
“Geen rechtsmiddel open, elke overdracht of overgang onder bijzondere of algemene titel,onder bezwarende titel of om niet,onder levenden of…” (deed in Dutch)
Share issue ruleHow and by whom new shares can be issued.
One provision in the deed

deed of 19-03-2025

Oversight and winding up

Dissolution ruleWhen and by whom the company can be dissolved.
One provision in the deed
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Cijfermatig verslag met rekeningen en stavingsstukken ten minste één maand voor algemene vergadering, slechts mits naleving wettelijke…” (deed in Dutch)

deed of 19-03-2025

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Uitgifte en vorm van aandelen en andere effecten, op zetel voor elke categorie effecten op naam,uittreksel als certificaat op…” (deed in Dutch)
Other provision: “Ondeelbaarheid van aandelen en andere effecten, vruchtgebruiker oefent alle verbonden rechten uit,tenzij statuten,testament of overeenkomst…” (deed in Dutch)
Other provision: “Aandeelhouders-toelating,beroepsuitoefening,aansprakelijkheid en schorsing, schikkingen meedelen aan Provinciale Raad Orde der Artsen van…” (deed in Dutch)
Other provision: “Onder voorwaarden bepaald in Wetboek van vennootschappen en verenigingen, Verkrijging eigen aandelen of certificaten” (deed in Dutch)
Other provision: “Algemene vergadering kan bij gewone meerderheid aan bepaalde bestuurders bezoldiging toekennen, Bezoldiging bestuurders” (deed in Dutch)
Other provision: “Alle handelingen nodig of dienstig tot verwezenlijking voorwerp,tenzij wet of statuten algemene vergadering bevoegd, Bestuursbevoegdheid” (deed in Dutch)
Other provision: “Inventaris-jaarrekening-jaarverslag, Nationale Bank van België” (deed in Dutch)
Other provision: “Winstbesteding-uitkeringen, verminderd met overgedragen verlies of vermeerderd met overgedragen winst” (deed in Dutch)
Other provision: “Verboden uitkeringen, van aandeelhouders ongeacht goede of kwade trouw bij strijd met winstbesteding-uitkeringen” (deed in Dutch)
Other provision: “Vennootschap van andere rechtsvorm, mag mits naleving wettelijke voorschriften en vormvereisten” (deed in Dutch)
Other provision: “Verwijzing naar wettelijke bepalingen voor al wat niet voorzien, wettelijke bepalingen” (deed in Dutch)
Other provision: “Aandeelhouder,bestuurslid,dagelijks bestuurder,commissaris,vereffenaar of voorlopig bewindvoerder kan op plaats professionele activiteit…” (deed in Dutch)
16 more provisions in the deed, see the deed of 19-03-2025

deed of 19-03-2025